Gumintad, Lea Mae P.
HRN: 24-99-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2024
CEFUROXIME 750MG (VIAL)
07/10/2024
07/17/2024
IV
120mg
Q8
Toxic Megacolon Sec To Hirschsprung’s Disease S/P Diverting Colostomy (05-18-23)
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes